Generalized exanthema and pulmonary embolism after the administration of AD26.COV2-S vaccine in a patient with recent history of SARS-COV2 infection (COVID-19): a case report

Several vaccines have appeared in recent times given the need for vaccinations against SARS-Cov2 (COVID-19) infection. General concern about their safety and possible adverse events has also emerged. We present the case of a patient with recent history of COVID-19 pneumonia who presented generalized exanthema and pulmonary embolism after being immunized withCOVID-19 Vaccine Janssen (Ad26.COV2-S).